BR9913154A - Composição de musse - Google Patents

Composição de musse

Info

Publication number
BR9913154A
BR9913154A BR9913154-4A BR9913154A BR9913154A BR 9913154 A BR9913154 A BR 9913154A BR 9913154 A BR9913154 A BR 9913154A BR 9913154 A BR9913154 A BR 9913154A
Authority
BR
Brazil
Prior art keywords
quick
agent
foaming agent
mousse
composition
Prior art date
Application number
BR9913154-4A
Other languages
English (en)
Inventor
Albert Zorko Abram
Original Assignee
Soltec Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3810055&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9913154(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soltec Res Pty Ltd filed Critical Soltec Res Pty Ltd
Publication of BR9913154A publication Critical patent/BR9913154A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Cosmetics (AREA)

Abstract

''COMPOSIçãO DE MUSSE'' Composição de espuma de aerossol para uso farmacêutico que inclui uma efetiva quantidade de um ingrediente farmaceuticamente ativo; um agente oclusivo; um solvente aquoso; e um co-solvente orgânico, o ingrediente farmaceuticamente ativo sendo insolúvel tanto em água e no agente oclusivo; o agente oclusivo estando presente em uma quantidade suficiente para formar uma camada oclusiva sobre a pele, durante o uso.
BR9913154-4A 1998-09-11 1999-09-08 Composição de musse BR9913154A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP5831A AUPP583198A0 (en) 1998-09-11 1998-09-11 Mousse composition
PCT/AU1999/000735 WO2000015193A1 (en) 1998-09-11 1999-09-08 Mousse composition

Publications (1)

Publication Number Publication Date
BR9913154A true BR9913154A (pt) 2001-05-15

Family

ID=3810055

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913154-4A BR9913154A (pt) 1998-09-11 1999-09-08 Composição de musse

Country Status (13)

Country Link
US (3) US6730288B1 (pt)
EP (2) EP1112062B1 (pt)
JP (1) JP4603164B2 (pt)
AT (1) ATE381315T1 (pt)
AU (2) AUPP583198A0 (pt)
BR (1) BR9913154A (pt)
CA (1) CA2333869C (pt)
DE (1) DE69937802T2 (pt)
DK (1) DK1112062T3 (pt)
ES (2) ES2299258T3 (pt)
NZ (1) NZ508259A (pt)
PT (1) PT1112062E (pt)
WO (1) WO2000015193A1 (pt)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
FR2761600B1 (fr) * 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
JP2003012501A (ja) * 2001-06-27 2003-01-15 Rohto Pharmaceut Co Ltd 鎮痒エアゾール製剤
US20050129722A1 (en) * 2002-03-13 2005-06-16 Collagenex Pharmaceuticals, Inc. Water-based delivery systems
ES2411656T3 (es) * 2002-03-13 2013-07-08 Thomas SKÖLD Sistemas de administración a base de agua
WO2004037225A2 (en) 2002-10-25 2004-05-06 Foamix Ltd. Cosmetic and pharmaceutical foam
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7645803B2 (en) * 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
CA2513773C (en) 2003-01-24 2013-03-26 Connetics Australia Pty Ltd Clindamycin phosphate foam
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
EP1623697A4 (en) * 2003-05-13 2008-03-19 Nisshin Oillio Group Ltd COSMETIC OIL IN WATER EMULSION
US7186416B2 (en) 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
JP4615198B2 (ja) * 2003-07-25 2011-01-19 久光製薬株式会社 抗真菌エアゾール外用製剤
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
MXPA06002163A (es) * 2003-08-25 2006-05-22 Foamix Ltd Espuma farmaceutica de penetracion.
CA2548892C (en) * 2003-12-12 2015-10-27 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
WO2005076697A2 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
ES2308170T3 (es) * 2004-04-05 2008-12-01 Laboratorios Liomont, S.A. De C.V. Nueva composicion farmaceutica antiviral.
EP1879595B1 (en) * 2005-05-10 2014-09-24 Dermipsor Ltd Compositions and methods for treating hyperproliferative epidermal diseases
US20060264344A1 (en) * 2005-05-23 2006-11-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Mild foaming cleansing composition
CA2611147C (en) * 2005-06-01 2013-04-09 Stiefel Research Australia Pty Ltd. Topical emulsion formulation
WO2007046102A2 (en) 2005-10-19 2007-04-26 Menni Menashe Zinger Methods for the treatment of hyperhidrosis
EP2206494B1 (en) 2006-03-31 2015-12-02 Stiefel Research Australia Pty Ltd Foamable suspension gel
PL2046121T3 (pl) * 2006-07-14 2013-01-31 Stiefel Res Australia Pty Ltd Farmaceutyczna pianka oparta na kwasie tłuszczowym
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
AR066901A1 (es) * 2007-05-18 2009-09-23 Alcon Mfg Ltd Composiciones fodfolipidicas para elcuidado de lentes de contacto y conservacion de composiciones farmaceuticas
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090558A2 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
PT2400951T (pt) 2009-02-25 2018-11-26 Mayne Pharma Llc Composições de espuma tópica
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
ES2537151T3 (es) 2009-12-10 2015-06-02 Neubourg Skin Care Gmbh & Co. Kg Formulaciones de espuma estabilizadas con polímeros, libres de emulsionantes
CN103491778B (zh) 2010-04-13 2017-05-31 雷尔玛达治疗股份有限公司 1‑甲基‑n‑(2，6‑二甲苯基)‑2‑哌啶甲酰胺的皮肤用药物组合物及其使用方法
PL2579852T3 (pl) 2010-06-11 2015-04-30 Leo Pharma As Farmaceutyczna kompozycja sprayu zawierająca analog witaminy D i kortykosteroid
WO2013011501A1 (en) 2011-07-20 2013-01-24 Perrigo Israel Pharmaceuticals Ltd Topical oily foam compositions
US8795696B2 (en) 2011-10-11 2014-08-05 Fallien Cosmeceuticals, Ltd. Foamable sunscreen formulation comprising pigments
WO2013065051A1 (en) 2011-11-01 2013-05-10 Naveh Pharma (1996) Ltd. Formulation and device for treating ceruminosis
CA2896429A1 (en) 2012-12-26 2014-07-03 Otic Pharma Ltd. Foamable otic pharmaceutical compositions
MX2016009215A (es) 2014-02-14 2017-02-17 Mission Pharma Co Dispositivo para suministro de rocio.
WO2015123238A1 (en) * 2014-02-14 2015-08-20 Mission Pharmacal Company Stabilized, sprayable emulsion containing active agent particles
US11007151B2 (en) 2014-02-14 2021-05-18 Mission Pharmacal Company Sprayable composition containing zinc oxide and a fluoro-olefin propellant
CN106456543B (zh) 2014-03-28 2021-01-22 盖尔德马研究及发展公司 包含过氧化苯甲酰的免洗型化学泡沫
US9265727B1 (en) 2015-01-14 2016-02-23 Delcor Asset Corporation Spray foam corticosteroid product
US10406088B2 (en) 2015-01-20 2019-09-10 TetraDerm Group LLC Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
CA2977737C (en) 2015-03-24 2020-08-18 The Procter & Gamble Company Foam compositions, aerosol products, and methods of using the same to improve sensory benefits to the skin
FR3041535B1 (fr) 2015-09-29 2019-01-25 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
FR3041536B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne.
FR3041539B1 (fr) * 2015-09-29 2018-10-26 Galderma Research & Development Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041538B1 (fr) * 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041537B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee.
FR3041541B1 (fr) 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee comprenant de l'ivermectine
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
US11617727B2 (en) 2019-04-30 2023-04-04 Bayer Healthcare Llc Topical analgesic gel compositions

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330730A (en) * 1962-08-03 1967-07-11 Colgate Palmolive Co Pressurized emulsion quick breaking foam compositions
US3829563A (en) * 1972-11-30 1974-08-13 Hoffmann La Roche Emollient cleansing compositions
LU71012A1 (pt) * 1974-09-26 1976-08-19
FR2350095A1 (fr) * 1976-05-03 1977-12-02 Oreal Compositions destinees a la coloration de la peau a base de derives de la pyridine
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
US4267173A (en) * 1979-11-05 1981-05-12 Schering Corporation Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4631064A (en) * 1982-06-01 1986-12-23 The Proctor & Gamble Company Depilatory compositions
US4618344A (en) * 1982-06-01 1986-10-21 The Procter & Gamble Company Depilatory compositions
GB8315787D0 (en) * 1983-06-08 1983-07-13 Briggs J H Coolant spray
US4607028A (en) * 1983-08-18 1986-08-19 Ciba-Geigy Corporation Novel carboxylic acid esters
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
DE3670569D1 (de) * 1985-03-01 1990-05-31 Procter & Gamble Milder reinigungsschaum.
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
JPH01156906A (ja) * 1987-09-23 1989-06-20 L'oreal Sa スキンコンデイショニングエアゾールフオーム組成物
US4981677A (en) * 1987-09-23 1991-01-01 L'oreal Petrolatum-containing aerosol foam concentrate
US5143717A (en) 1987-12-30 1992-09-01 Code Blue Medical Corporation Burn foam and delivery system
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
WO1991001712A1 (fr) * 1989-07-28 1991-02-21 Hisamitsu Pharmaceutical Co., Inc. Preparation pour aerosol en mousse
US5037655A (en) * 1990-04-18 1991-08-06 Giovanoni Richard L Method of stabilizing tretinoin
US5167950A (en) * 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
US5252331A (en) * 1992-03-05 1993-10-12 Lorenzo Freeman Less irritating shaving material
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
ES2139890T3 (es) * 1994-03-24 2000-02-16 Ciba Sc Holding Ag Alquil esteres de dl- di- o tri-hidroxifenilglicina para el tratamiento de estados inflamatorios y alergicos.
US5976555A (en) * 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
GB9504265D0 (en) * 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
EP0738510A3 (fr) 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
US5902805A (en) * 1996-04-22 1999-05-11 L'oreal Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
DE19631221C2 (de) * 1996-08-02 1999-07-01 Beiersdorf Ag Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
GB2327344A (en) * 1997-07-18 1999-01-27 Ninh Thuy On Pharmaceutical compositions containing phenytoin and either an azole anti-fungal/anti-bacterial agent and/or a silver salt for topical application
US5965500A (en) 1997-07-24 1999-10-12 Levers Brothers Company, Division Of Conopco, Inc. Stable liquid composition comprising high levels of emollients
DK1014916T4 (da) * 1997-08-18 2011-09-26 Neubourg Skin Care Gmbh & Co Kg Skum-hudbeskyttelsescreme
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
CA2530407A1 (en) * 2003-07-23 2005-02-03 The Regents Of The University Of California Penetration enhancer combinations for transdermal delivery
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis

Also Published As

Publication number Publication date
AU760153B2 (en) 2003-05-08
EP1872776A3 (en) 2008-07-23
AU6069299A (en) 2000-04-03
DE69937802D1 (de) 2008-01-31
US20040184992A1 (en) 2004-09-23
JP2002524490A (ja) 2002-08-06
EP1112062A4 (en) 2005-06-08
AUPP583198A0 (en) 1998-10-01
ES2299258T3 (es) 2008-05-16
US20060104912A1 (en) 2006-05-18
EP1872776A2 (en) 2008-01-02
ES2431330T3 (es) 2013-11-26
US7029659B2 (en) 2006-04-18
WO2000015193A1 (en) 2000-03-23
CA2333869A1 (en) 2000-03-23
EP1872776B1 (en) 2013-07-24
EP1112062B1 (en) 2007-12-19
US6730288B1 (en) 2004-05-04
DE69937802T2 (de) 2008-12-04
NZ508259A (en) 2003-11-28
CA2333869C (en) 2009-01-06
EP1112062A1 (en) 2001-07-04
PT1112062E (pt) 2008-03-24
DK1112062T3 (da) 2008-04-28
ATE381315T1 (de) 2008-01-15
JP4603164B2 (ja) 2010-12-22

Similar Documents

Publication Publication Date Title
BR9913154A (pt) Composição de musse
DK0813413T3 (da) Corticosteroidholdigt skum
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
EP1184031A3 (fr) Crème cosmétique moussante pour le traitement des peaux grasses
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
EP2108360A3 (en) Topical Pharmaceutical Foam Composition
PE11495A1 (es) Copolimero elastomerico termoplastico injertado con silicona y composicion para el cuidado del cabello y de la piel que lo contiene
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
DK0752898T3 (da) Mindskning af hudirritation ved elektrotransport-tilførsel
BR9407018A (pt) Copolímeros elastoméricos termoplásticos e composições para o cuidado da pele e do cabelo contendo os mesmos
AR007582A1 (es) Composicion para el lavado de la piel, procedimiento para prepararla y el uso de la misma para la fabricacion de medicamentos dado el caso, para eltratamiento cosmetico de la piel.
AR015594A1 (es) Articulos absorbentes que tienen punos de pierna con locion que contienen un emoliente de polisiloxano
BR0014530A (pt) Espumas e composições contendo estas espumas
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
NZ516765A (en) Topical formulations comprising skin penetration agents and the use thereof
ES2172095T3 (es) Utilizacion de sulfitos y metabisulfitos, para la fabricacion de composiciones cosmeticas o farmaceuticas, particularmente en dermatologia, con efecto inhibidor de la melanogenesis o con actividad despigmentante.
WO2002028361A3 (en) Compositions for cleansing skin and treating acne
US6528072B1 (en) Topical composition for skin including witch hazel
DE50111782D1 (de) Treibgasfreie Sprayzubereitungen
ATE206037T1 (de) Aerosol-schaumdauerwellzusammensetzung

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: STIEFEL RESEARCH AUSTRALIA PTY LTD. (AU)

Free format text: ALTERADO DE: CONNETICS AUSTRALIA PTY LTD.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O, 11 E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]